Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug.
Their research, published today in the journal Molecular Pharmaceutics, shows how a new anti-heroin formulation that is safe in animal models remains stable at room temperature for at least 30 days. As a result, the vaccine is close to being ready for human testing.
“The heroin vaccine is one step closer to clinical evaluation,” says Candy S. Hwang, PhD, first author of the study and a research associate at TSRI.
According to the National Institute on Drug Abuse, 15,446 Americans died from heroin overdose between 2000 and 2016, and the mortality rates are increasing. Heroin abuse has been further fueled by a rise in prescription opioid abuse—studies show that opioid pain reliever users are 40 times more likely to abuse heroin.
The first formulation of the heroin vaccine was developed in 2013 by a team led by Kim D. Janda, PhD, the Ely R. Callaway Jr. Professor of Chemistry and member of the Skaggs Institute for Chemical Biology at TSRI. It has been shown to be effective—and safe—in both mouse and non-human primate models.
The vaccine works by training the immune system antibodies to recognize and bind to heroin molecules, blocking the drug from reaching the brain to cause a “high.” Researchers believe that blocking the high of heroin will help eliminate the motivation for many recovering addicts to relapse into drug use.
The heroin molecule does not naturally prompt an antibody response, so researchers attach it to a carrier protein that alerts the immune system to start making antibodies. Scientists also add an ingredient called an adjuvant to the vaccine, which boosts the immune response and makes the vaccine more effective.
Hwang says, “Our goal was to prepare a vaccine that could be advanced to clinical trials. As such, we were looking for the best combination of ‘hapten’ (the heroin molecule), carrier protein and adjuvant to keep the vaccine both stable for transport and storage but still efficacious.”
For the new study, the researchers investigated how 20 different carrier protein/adjuvant combinations worked, including shelf stability based on temperature and storage time and whether the formulation was a liquid or powder.
Their experiments in rodent models showed that the best vaccine formulation contained a carrier protein called tetanus toxoid (TT) and adjuvants called alum and CpG ODN. The discovery that alum worked best as an adjuvant was especially significant since alum is one of the few adjuvants used in vaccines already approved by the U.S. Food and Drug Administration. The researchers also found that there was no difference in how well it worked between the liquid and powder versions of this formulation.
Hwang notes that the best vaccine formulation showed protection against lethal doses of heroin. This is particularly important as many heroin addicts have succumb to overdose and death during their attempts to quit the drug.
With this new study, the researchers have shown that the vaccine is safe and effective in animal models, stable under clinical conditions and reliant on an already-approved adjuvant. The next step is to find a producer to make the vaccine on a large scale.
“We believe that a heroin vaccine would be tremendously beneficial for people who have a heroin substance use disorder but have found difficulty in trying to quit,” says Hwang.
Learn more: Heroin vaccine blocks lethal overdose
The Latest on: Heroin vaccine
via Google News
The Latest on: Heroin vaccine
- Depression Makes People More Susceptive to Vaccine-related Misinformationon January 22, 2022 at 8:29 am
The new study found that people with symptoms of depression were more likely to believe false statements about COVID-19 vaccines.
- Vaccine passport protests in Europe draw thousands of peopleon January 22, 2022 at 7:39 am
Thousands of people gathered in European capitals Saturday to protest vaccine passports and other requirements governments have imposed in hopes of ending the coronavirus pandemic.
- California teens could soon get COVID-19 vaccine without parental permissionon January 21, 2022 at 8:29 pm
Young people in California could soon have more autonomy to get the COVID-19 shot and other vaccinations without parental consent, a move State. Sen Scott Wiener says will give mi ...
- FDA authorizes antiviral drug remdesivir as an outpatient therapy for people with covid-19on January 21, 2022 at 4:20 pm
The move gives doctors and high-risk patients an additional option for treating mild-to-moderate illness caused by the coronavirus.
- The Shameless, Radical Ruling Against Biden’s Civil Service Vaccine Mandateon January 21, 2022 at 3:47 pm
U.S. District Court Judge Jeffrey Vincent Brown blocked President Joe Biden’s COVID-19 vaccine mandate for the federal workforce and issued a nationwide injunction ensuring no other district court ...
- Organized on Facebook, a ‘who’s who’ of anti-vaccine activists head to D.C.on January 21, 2022 at 1:22 pm
Thousands of protesters are expected to descend on Washington this weekend for a rally against Covid-19 vaccine mandates,.
- Recommendations updated for recombinant zoster vaccineon January 21, 2022 at 9:00 am
(HealthDay)—Recommendations have been updated for use of the recombinant zoster vaccine (RZV) for prevention of herpes zoster and related complications among immunocompromised adults aged 19 years and ...
- People suffering from depression susceptive to vaccine-related misinformationon January 21, 2022 at 8:15 am
People who feel depressed are more likely to believe vaccine-related misinformation, according to a new study coauthored by a Rutgers researcher during a time when depression rates are higher due to ...
- Fauci says he hopes FDA will authorize Pfizer's Covid vaccine for kids under 5 in the next monthon January 21, 2022 at 5:36 am
Fauci said younger children will likely need three doses, because two shots did not induce an adequate immune response in children 2 to 4 years old.
- Fauci Says the FDA Could Approve the COVID Vaccine for Kids Under 5 Next Monthon January 20, 2022 at 10:41 am
BioNTech's COVID-19 vaccine within the next month, Dr. Anthony Fauci said Wednesday. Fauci, the nation's top infectious disease expert, said that it's his "hope" that the Food and Drug Administration ...
via Bing News